Cativa CBD Announces Athlete Challenge for the 2020 Professional Golf Association Tour
The CBD brand offers over $160,000 in prize money to participating professional golfers
Portsmouth, VA, June 23, 2020—Cativa CBD, a science-based cannabidiol (CBD) brand set to revolutionize the wellness and CBD industries, announced today that the company has launched a challenge for professional golfers with a total purse over $160,000 in prize money.
“The PGA Tour returned to action at the beginning of the month and Cativa CBD is excited to bring fans some additional excitement with the announcement of the challenge. As the 2020 PGA tour kicks off, we are excited here at Cativa to have the honor of supporting these professional athletes,” said Luisa Escobar, chief operating officer of Cativa CBD. “These athletes are a prime example of how responsible use of CBD improves play and recovery.” The players will have unlimited supply of Cativa CBD’s array of products to include CBD gum and CBD Iced Coffee.
The Cativa CBD PGA Challenge started on June 11, 2020, at the Charles Schwab Challenge and will run through the end of the 2021 season. The participating Challenge players are: Brian Gay, Mike Gellerman, Hank Lebioda, Rory Sabbatini, Chris Stroud, Hudson Swafford, Michael Thompson, and D.J. Trahan.
The Challenge is structured in such a fashion that athletes are required to play a minimum of 25 events throughout the season. Players can participate in many ways to earn points. Each athlete starts with points based on Cativa CBD logo placement(s) and they will accumulate additional points based on PGA tour winnings & social media posts promoting Cativa CBD throughout the remainder of the 2020 season and through the 2021 season. Fans will be able to stay up to date with the rankings on www.cativacbd.com/pga-challenge
For more information about Cativa CBD and to order products, please visit www.cativacbd.com. Samples, photos, and interviews with leadership are available upon request.
Cativa CBD is a science-backed CBD brand committed to creating products that work. Founded in 2018, Cativa CBD is dedicated to using the latest in cutting-edge technology and zero-THC CBD isolates. Cativa CBD was founded with a simple mission: to combine the power of science and the promise of nature to deliver wellness and health. We believe in the untapped potential of CBD to heal the mind and body. And, we are committed to building a limitless future where technology and nature work together. We are passionate about science, sustainability, and promoting human health and the environment. And, we are passionate about you. Cativa is sold at high-end retailers and via www.CativaCBD.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease.
Cativa CBD does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US CSA). The company sells and distributes hemp-based products. Cannabidiol is a natural constituent of hemp.
Allyson Markey, PR Manager